133 related articles for article (PubMed ID: 38353621)
21. Generation of PDX-1 mutant porcine blastocysts by introducing CRISPR/Cas9-system into porcine zygotes via electroporation.
Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
Anim Sci J; 2019 Jan; 90(1):55-61. PubMed ID: 30368976
[TBL] [Abstract][Full Text] [Related]
22. Frequency of off-targeting in genome edited pigs produced via direct injection of the CRISPR/Cas9 system into developing embryos.
Carey K; Ryu J; Uh K; Lengi AJ; Clark-Deener S; Corl BA; Lee K
BMC Biotechnol; 2019 May; 19(1):25. PubMed ID: 31060546
[TBL] [Abstract][Full Text] [Related]
23. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
[TBL] [Abstract][Full Text] [Related]
24. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-Associated Endonuclease Cas9-Mediated Homology-Independent Integration for Generating Quality Control Materials for Clinical Molecular Genetic Testing.
Lin G; Zhang K; Peng R; Han Y; Xie J; Li J
J Mol Diagn; 2018 May; 20(3):373-380. PubMed ID: 29680088
[TBL] [Abstract][Full Text] [Related]
25. Exome sequencing in the knockin mice generated using the CRISPR/Cas system.
Nakajima K; Kazuno AA; Kelsoe J; Nakanishi M; Takumi T; Kato T
Sci Rep; 2016 Oct; 6():34703. PubMed ID: 27698470
[TBL] [Abstract][Full Text] [Related]
26. No off-target mutations in functional genome regions of a CRISPR/Cas9-generated monkey model of muscular dystrophy.
Wang S; Ren S; Bai R; Xiao P; Zhou Q; Zhou Y; Zhou Z; Niu Y; Ji W; Chen Y
J Biol Chem; 2018 Jul; 293(30):11654-11658. PubMed ID: 29941452
[TBL] [Abstract][Full Text] [Related]
27. Genome editing with CRISPR/Cas9 in Pinus radiata (D. Don).
Poovaiah C; Phillips L; Geddes B; Reeves C; Sorieul M; Thorlby G
BMC Plant Biol; 2021 Aug; 21(1):363. PubMed ID: 34376154
[TBL] [Abstract][Full Text] [Related]
28. The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones.
Watanabe S; Sakurai T; Nakamura S; Miyoshi K; Sato M
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617297
[TBL] [Abstract][Full Text] [Related]
29. Whole genome analysis for 163 gRNAs in Cas9-edited mice reveals minimal off-target activity.
Peterson KA; Khalouei S; Hanafi N; Wood JA; Lanza DG; Lintott LG; Willis BJ; Seavitt JR; Braun RE; Dickinson ME; White JK; Lloyd KCK; Heaney JD; Murray SA; Ramani A; Nutter LMJ
Commun Biol; 2023 Jun; 6(1):626. PubMed ID: 37301944
[TBL] [Abstract][Full Text] [Related]
30. Achieving Plant CRISPR Targeting that Limits Off-Target Effects.
Wolt JD; Wang K; Sashital D; Lawrence-Dill CJ
Plant Genome; 2016 Nov; 9(3):. PubMed ID: 27902801
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
Sugano SS; Nishihama R
Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
[TBL] [Abstract][Full Text] [Related]
33. Cas9 Cuts and Consequences; Detecting, Predicting, and Mitigating CRISPR/Cas9 On- and Off-Target Damage: Techniques for Detecting, Predicting, and Mitigating the On- and off-target Effects of Cas9 Editing.
Newman A; Starrs L; Burgio G
Bioessays; 2020 Sep; 42(9):e2000047. PubMed ID: 32643177
[TBL] [Abstract][Full Text] [Related]
34. Efficient CRISPR/Cas9-based gene knockout in watermelon.
Tian S; Jiang L; Gao Q; Zhang J; Zong M; Zhang H; Ren Y; Guo S; Gong G; Liu F; Xu Y
Plant Cell Rep; 2017 Mar; 36(3):399-406. PubMed ID: 27995308
[TBL] [Abstract][Full Text] [Related]
35. Efficient genome editing of Brassica campestris based on the CRISPR/Cas9 system.
Xiong X; Liu W; Jiang J; Xu L; Huang L; Cao J
Mol Genet Genomics; 2019 Oct; 294(5):1251-1261. PubMed ID: 31129735
[TBL] [Abstract][Full Text] [Related]
36. CRISPR-Cas9-Edited Site Sequencing (CRES-Seq): An Efficient and High-Throughput Method for the Selection of CRISPR-Cas9-Edited Clones.
Veeranagouda Y; Debono-Lagneaux D; Fournet H; Thill G; Didier M
Curr Protoc Mol Biol; 2018 Jan; 121():31.14.1-31.14.11. PubMed ID: 29337372
[TBL] [Abstract][Full Text] [Related]
37. Editing MC1R in human melanoma cells by CRISPR/Cas9 and functional analysis.
Zhang C; Wei ZX; Wang M; Chen YS; He ZY
Yi Chuan; 2022 Jul; 44(7):581-590. PubMed ID: 35858770
[TBL] [Abstract][Full Text] [Related]
38. Effect of ARTEMIS (DCLRE1C) deficiency and microinjection timing on editing efficiency during somatic cell nuclear transfer and in vitro fertilization using the CRISPR/Cas9 system.
Li Y; Adur MK; Wang W; Schultz RB; Hale B; Wierson W; Charley SE; McGrail M; Essner J; Tuggle CK; Ross JW
Theriogenology; 2021 Aug; 170():107-116. PubMed ID: 34004455
[TBL] [Abstract][Full Text] [Related]
39. The novel insight into the outcomes of CRISPR/Cas9 editing intra- and inter-species.
Chang J; Chen X; Zhang T; Wang R; Wang A; Lan X; Zhou Y; Ma S; Xia Q
Int J Biol Macromol; 2020 Nov; 163():711-717. PubMed ID: 32652159
[TBL] [Abstract][Full Text] [Related]
40. Efficient CRISPR/Cas9-based genome editing in carrot cells.
Klimek-Chodacka M; Oleszkiewicz T; Lowder LG; Qi Y; Baranski R
Plant Cell Rep; 2018 Apr; 37(4):575-586. PubMed ID: 29332168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
